Leading brain surgeons push back against UnitedHealthcare’s denials, revealing how insurer power causes delays and impacts patient care and outcomes.

Few stocks have been as resilient as UnitedHealth Group (NYSE: UNH). The company operates the largest health insurance business in the U.S. It runs the second biggest pharmacy benefits manager (PBM).

Few stocks have been as resilient as UnitedHealth Group (UNH 0.49%). The company operates the largest health insurance business in the U.S. It runs the second biggest pharmacy benefits manager (PBM).

GENERATION. THE USA PICKLEBALL GOLDEN TICKET TOURNAMENT IS IN OVERLAND PARK. KMBC NINE S ALAN SHOPE TELLS US. NEW PICKLEBALL COURTS WILL HOST ALL SKILL LEVELS. I’LL TRAVEL ANYWHERE TO PLAY ...

Shares of UnitedHealth Group plunged more than 13% on Thursday following a report that the Department of Justice is conducting a criminal investigation into the health-care giant over possible ...

The stock price of UnitedHealth Group (NYSE: UNH) is sinking yet again this morning after reports that the private healthcare company is now under criminal investigation by the Department of ...

UnitedHealth Group is being investigated for possible Medicare fraud, according to The Wall Street Journal, sending shares of the healthcare company sliding in after-hours trading just one day ...

UnitedHealth Group CEO Andrew Witty stepped down from his executive role in May 2025. The company announced his successor that month in a press release and cited the reason for Witty’s departure.

May 13 (UPI) --UnitedHealth Group announced Tuesday CEO Andrew Witty will step down, citing "personal reasons." Witty will leave the role of CEO and be replaced by Stephen J. Hemsley, effective ...

UnitedHealth Group CEO Andrew Witty will step down from his role at the top of the company due to personal reasons, the healthcare giant announced Tuesday morning. Stephen Hemsley, who previously ...

UnitedHealth Group's CEO will step down, and a familiar face will be taking the helm of the company, which said it "expects to return to growth in 2026" despite higher-than-expected medical costs ...